Wiesener, Michael S.

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature

Cancer, Hypoxia, and MetabolismErythropoietin and Anemia Treatment

Cited by 5,180

Hypoxia and Hypoxia-Inducible Factor-1α Modulate Lipopolysaccharide-Induced Dendritic Cell Activation and Function

Jantsch, J., Chakravortty, D., Turza, N., Prechtel, A. T., Buchholz, B., Gerlach, R. G., Volke, M., Gläsner, J., Warnecke, C., Wiesener, M. S., et al. (2008) · The Journal of Immunology

Cancer, Hypoxia, and MetabolismImmunotherapy and Immune Responses

Cited by 414

Inhibition of Prolyl Hydroxylases Increases Erythropoietin Production in ESRD

Bernhardt, W. M., Wiesener, M. S., Scigalla, P., Chou, J., Schmieder, R. E., Günzler, V., & Eckardt, K.-U. (2010) · Journal of the American Society of Nephrology

Erythropoietin and Anemia TreatmentHemoglobin structure and function

Cited by 340

HIF is not essential for suppression of experimental tumor growth by mTOR inhibition

Knaup, K. X., Guenther, R., Stoeckert, J., Monti, J. M., Eckardt, K.-U., & Wiesener, M. S. (2017) · Journal of Cancer

Cancer, Hypoxia, and MetabolismPI3K/AKT/mTOR signaling in cancer

Cited by 7